Live Breaking News & Updates on Renal thromboembolic disease associated

Allogene Therapeutics Presents Interim Phase 1 Data on ALLO-316 in Renal Cell Carcinoma at the American Association of Cancer Research (AACR) Annual Meeting

Data Provide Proof-of-Concept for an Allogeneic Anti-CD70 CAR T Candidate in Patients with Renal Cell Carcinoma Who Received Prior Immune Checkpoint Inhibitor and VEGF-Targeting TherapySingle. | April 17, 2023

Florida , United-states , Orlando , Texas , American , Allogene-allo , Christine-cassiano , Zachary-roberts , Samera-srour , University-of-texas-md-anderson-cancer-center , Linkedin , Research-development

Veklury® (Remdesivir) Efficacy and Safety Profile Further Demonstrated in Vulnerable Patient Populations

– Phase 3 Clinical Trial Demonstrated the Safety Profile of Veklury in Patients with Severe Renal Impairment –

– Real-World Evidence Demonstrated Veklury Reduced COVID-19-. | April 16, 2023

Milan , Lombardia , Italy , California , United-states , Foster-city , Frank-duff , Michele-bartoletti , Gilead-sciences , Exchange-commission , Gilead-sciences-inc , Professor-of-humanitas-university

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at Planet MicroCap Showcase

Mr. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease and Inflammasome ASC Inhibitor IC 100. | April 11, 2023

Casey-mcdonald , Dave-schemelia , Las-vegas , Stephenc-glover , Zyversa-therapeutics-inc , Nasdaq , Tiberend-strategic-advisors-inc , Company-presentations , Horseshoe-hotel-casino , Securities-exchange , Cholesterol-efflux-mediator , Versa-therapeutics

Aiosyn, Pathomation, and Radboud University Medical Center Are Awarded 1,6M € Eurostars Grant to Develop AI-Powered Solutions for Renal Diagnostics

Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a 1,6M Eurostars grant together with Pathomation and Radboud university medical center to accelerate

Netherlands , Nijmegen , Gelderland , Dutch , Anna-correas , Rudy-hovelinck , European-union , Image-management-software , Marketing-communications-specialist-at-aiosyn , European-partnership-on-innovative-smes , Assisted-kidney , Kidney-disease

HistoSonics Commences CAIN Trial of Histotripsy Platform to Treat Renal Tumors

April 5, 2023—HistoSonics recently announced that the first kidney patient has been treated using the company’s histotripsy platform. The

Michigan , United-states , United-kingdom , Ann-arbor , Charles-cain , Histosonics-edison , University-of-michigan , Professor-tze-min-wah , Senior-consultant-radiologist , Clinical-lead , Interventional-oncology-program , Leeds-teaching-hospitals